These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2877420)

  • 1. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
    Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
    Kowall NW; Beal MF
    Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type.
    Gaspar P; Duyckaerts C; Febvret A; Benoit R; Beck B; Berger B
    Brain Res; 1989 Jun; 490(1):1-13. PubMed ID: 2569349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia.
    Chan-Palay V
    J Comp Neurol; 1987 Jun; 260(2):201-23. PubMed ID: 2886516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-like immunoreactivity within neuritic plaques.
    Armstrong DM; LeRoy S; Shields D; Terry RD
    Brain Res; 1985 Jul; 338(1):71-9. PubMed ID: 2862952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia.
    Chan-Palay V; Lang W; Allen YS; Haesler U; Polak JM
    J Comp Neurol; 1985 Aug; 238(4):390-400. PubMed ID: 2413088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptides and neuropathology in the amygdala in Alzheimer's disease: relationship between somatostatin, neuropeptide Y and subregional distribution of neuritic plaques.
    Unger JW; McNeill TH; Lapham LL; Hamill RW
    Brain Res; 1988 Jun; 452(1-2):293-302. PubMed ID: 2900051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatostatin- and neuropeptide Y-immunoreactive cortical neurons in senile dementia of Alzheimer type].
    Nakamura S; Akiguchi I; Kameyama M; Nakamura N; Kimura H
    Nihon Ronen Igakkai Zasshi; 1986 Nov; 23(6):594-9. PubMed ID: 2882040
    [No Abstract]   [Full Text] [Related]  

  • 9. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
    Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
    Candy JM; Gascoigne AD; Biggins JA; Smith AI; Perry RH; Perry EK; McDermott JR; Edwardson JA
    J Neurol Sci; 1985 Dec; 71(2-3):315-23. PubMed ID: 2868073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
    Minthon L; Edvinsson L; Gustafson L
    Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y-like immunoreactivity in neuritic plaques of Alzheimer's disease.
    Dawbarn D; Emson PC
    Biochem Biophys Res Commun; 1985 Jan; 126(1):289-94. PubMed ID: 3838246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Tran VT; Chattha G; Bird ED; Martin JB
    Science; 1985 Jul; 229(4710):289-91. PubMed ID: 2861661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
    Dawbarn D; De Quidt ME; Emson PC
    Brain Res; 1985 Aug; 340(2):251-60. PubMed ID: 2862959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Chattha GK; Svendsen CN; Bird ED; Martin JB
    Ann Neurol; 1986 Sep; 20(3):282-8. PubMed ID: 3767313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective lesion of the cholinergic basal forebrain causes a loss of cortical neuropeptide Y and somatostatin neurons.
    Zhang ZJ; Lappi DA; Wrenn CC; Milner TA; Wiley RG
    Brain Res; 1998 Aug; 800(2):198-206. PubMed ID: 9685641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphology and distribution of neuropeptide-containing neurons in human cerebral cortex.
    Hornung JP; De Tribolet N; Törk I
    Neuroscience; 1992 Nov; 51(2):363-75. PubMed ID: 1281528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration.
    Minthon L; Edvinsson L; Ekman R; Gustafson L
    J Neural Transm Suppl; 1990; 30():57-67. PubMed ID: 1975266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
    Leake A; Perry EK; Perry RH; Jabeen S; Fairbairn AF; McKeith IG; Ferrier IN
    Biol Psychiatry; 1991 Feb; 29(4):357-64. PubMed ID: 1674664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex.
    German DC; White CL; Sparkman DR
    Neuroscience; 1987 May; 21(2):305-12. PubMed ID: 3302759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.